Inflammatory Biomarkers in Diffuse Large B-Cell Lymphoma: Time for Extending the Established Prognosis Scores?

Publisher： Karger

E-ISSN： 1421-9662|137|2|73-75

ISSN： 0001-5792

Source： Acta Haematologica, Vol.137, Iss.2, 2017-01, pp. : 73-75

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

MYC protein expression is associated with poor prognosis in primary diffuse large B‐cell lymphoma of the central nervous system

By  

APMIS (ELECTRONIC), Vol. 123, Iss. 7, 2015-07 ,pp. : 596-603

John Wiley & Sons Inc

Access to resources Recommend Favorite

Primary central nervous system diffuse large B‐cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart

By  

HISTOPATHOLOGY, Vol. 309-0167, Iss. 5, 2015-11 ,pp. : 625-635

John Wiley & Sons Inc

Access to resources Recommend Favorite

Primary central nervous system diffuse large B‐cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart

By  

HISTOPATHOLOGY, Vol. 67, Iss. 5, 2015-11 ,pp. : 625-635

John Wiley & Sons Inc

Access to resources Recommend Favorite

Immunohistochemical Expression of Multidrug Resistance Proteins as a Predictor of Poor Response to Chemotherapy and Prognosis in Patients with Nodal Diffuse Large B-Cell Lymphoma

By  

Oncology, Vol. 68, Iss. 4-6, 2005-08 ,pp. : 422-431

Karger

Access to resources Recommend Favorite

Reduced expression of TRIM21/Ro52 predicts poor prognosis in diffuse large B‐cell lymphoma patients with and without rheumatic disease

By  

JOURNAL OF INTERNAL MEDICINE, Vol. 278, Iss. 3, 2015-09 ,pp. : 323-332

John Wiley & Sons Inc

Access to resources Recommend Favorite